Bausch + Lomb Corporation (BLCO)
NYSE · Manufacturing · Ophthalmic goods
BLCO price, last 12 months
Key stats
- Previous close
- $16.80
- Open
- $16.92
- Day range
- $16.82 – $16.98
- 52-week range
- $13.77 – $18.92
- Volume
- 162.1K
- Avg volume (20 days)
- 376.9K
- Market cap
- $6.0B
Performance
Technicals and fundamentals
About Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
- Sector
- Manufacturing
- Industry
- Ophthalmic goods
- Listed on
- NYSE
- Market cap
- $6.0B